Showing results (1-10 of 986) with videos related to

Sort By:
Pageof 99
Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.
Cancer|March 18, 2021
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approachHagop M Kantarjian, Tapan M Kadia, Courtney D DiNardo, et al.
Leukemia|June 16, 2021
Therapeutic implications of menin inhibition in acute leukemiasGhayas C Issa, Farhad Ravandi, Courtney D DiNardo, et al.
Cancer Discovery|February 5, 2020
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New ChallengesNicholas J Short, Marina Konopleva, Tapan M Kadia, et al.
Cancer|March 19, 2025
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challengesJayastu Senapati, Tapan M Kadia, Naval G Daver, et al.
Blood Cancer Discovery|November 20, 2024
Venetoclax-Based Combination Regimens in Acute Myeloid LeukemiaHannah Goulart, Hagop Kantarjian, Naveen Pemmaraju, et al.
Human Pathology|May 31, 2026
The Role of Advanced Molecular Diagnostics in Informing Targeted Therapies for AMLJennifer Marvin-Peek, Sanam Loghavi, Ghayas C Issa, et al.
Cancer|April 5, 2021
De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017Koji Sasaki, Farhad Ravandi, Tapan M Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2015
Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor SurvivalDavid Sanford, Courtney D DiNardo, Guilin Tang, et al.
American Journal of Hematology|January 23, 2016
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)Courtney D DiNardo, Guillermo Garcia-Manero, Sherry Pierce, et al.
Pageof 99